NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/13/2026 10:07
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization867.89 mln
Float41.04 mln
Earnings Date05/19/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-1.86
Caution advised
1-Year Forecast
26.20
Transformational upside
Relative Strength
81
/ 100
Strongly outperforming
Debt / Equity
0.84
Moderate leverage
ROE
-91.12
Deeply negative
Business Description
ARS Pharmaceuticals is a San Diego-based drug company focused on making emergency allergy treatments more accessible. Its main product, neffy, delivers epinephrine through the nose rather than by injection, offering a needle-free option for people experiencing severe allergic reactions such as anaphylaxis. Founded in 2015, the company sells its products in the United States and abroad.
